The healthcare data monetization market is projected to reach USD 1.3 billion by 2031 from USD 0.7 billion in 2026, at a CAGR of 14.5% during the forecast period
The healthcare data monetization market is driven by several key factors, including the rapid adoption of electronic health records (EHRs) that generate vast volumes of patient data, creating new opportunities for analysis and value extraction. Additionally, the rising use of external data sources and integration of large, complex healthcare datasets fuel market expansion. The urgent need to control escalating healthcare costs motivates providers and payers to leverage data for more efficient operations and better patient outcomes. Furthermore, advancements in AI, machine learning, and cloud computing enable sophisticated analytics and scalable data processing, facilitating innovative monetization strategies across the healthcare ecosystem.
Emerging technologies such as blockchain are enhancing data security and transparency, enabling secure and compliant healthcare data sharing across stakeholders. Advances in artificial intelligence (AI) and machine learning (ML) are driving deeper insights from complex datasets, facilitating personalized medicine and predictive analytics. The growing adoption of Internet of Medical Things (IoMT) devices generates real-time patient data, expanding monetization opportunities. For instance, in January 2026, Boehringer Ingelheim selected IQVIA’s Data-as-a-Service (DaaS+) platform to support global commercial data harmonization across 59 countries. The initiative is designed to integrate commercial datasets into a unified cloud-based data foundation and enable advanced analytics and AI-powered decision-making. This is a strong example of the market moving beyond simple data licensing toward data-as-a-service and analytics-driven monetization.
The direct data monetization segment accounted for the largest share of the healthcare data monetization market
The healthcare data monetization market is segmented into two types: direct and indirect data monetization. In 2025, the direct segment held the largest market share, driven by the increasing demand from healthcare organizations to generate immediate revenue through the sale or licensing of data assets. This direct data monetization segment is further divided into software and services. The software segment is projected to account for the largest share, fueled by the growing adoption of data analytics platforms, data integration tools, and secure data exchange solutions that facilitate real-time data monetization. These software solutions provide scalability, automation, and compliance features, making them essential for organizations seeking to manage and commercialize large volumes of health data efficiently.
The cloud segment is projected to grow at the highest CAGR in the healthcare data monetization market by deployment type
The healthcare data monetization market includes on-premises and cloud models, with the cloud segment expected to grow the fastest. This growth is fueled by the scalability, cost-efficiency, and integration ease of cloud solutions, allowing healthcare organizations to manage large volumes of data effectively. Major tech companies are investing in cloud-based healthcare innovations. For instance, in March 2026, CVS Health announced a strategic partnership with Google Cloud to build Health100, an AI-native healthcare consumer platform. The platform uses Google Cloud’s Gemini, Cloud Healthcare API, and BigQuery to connect data across pharmacies, providers, insurers, and digital health services, illustrating how cloud infrastructure is being used to aggregate and derive value from healthcare data.
North America accounted for the largest share of the healthcare data monetization market in 2025
In 2025, North America led the healthcare data monetization market, thanks to its advanced digital infrastructure, strong regulatory support, and an active investment landscape. The widespread adoption of electronic health records (EHRs), telehealth platforms, and connected devices has established a solid foundation for data generation and monetization. Regulatory initiatives like the 21st Century Cures Act in the US have encouraged data interoperability and improved patient access, promoting the broader use of health data for secondary purposes. Moreover, the presence of major technology and healthcare IT companies such as Oracle, IBM, Microsoft, and Salesforce has sped up the development and implementation of cloud-based, AI-enabled monetization solutions. The US is the major revenue contributor in North America, supported by large healthcare datasets, advanced data analytics capabilities, and growing investments in healthcare AI and cloud platforms. MarketsandMarkets
Medical image analysis software market to hit USD 6.3B
